Neocutis Journée Extra Moisturizing Revitalizing & Refining Day Cream SPF 30 protects and nourishes the skin to help you maintain long-lasting hydration. This multi-purpose day cream infuses antioxidants into the skin to protect against environmental damage by neutralizing free radicals while Human Growth Factors target premature signs of aging by tightening sagging skin, softening fine lines and wrinkles, and evening out hyperpigmentation for a smooth complexion. This broad-spectrum sunscreen protects against UVA and UVB rays.
Key Benefits
- Anti-aging growth factors – Helps reduce appearance of fine lines and wrinkles; supports collagen
- Revitalizing proprietary peptides – Helps support elastin and hyaluronic acid to revitalize skin elasticity and firmness
- Hydrates – Provides lasting hydration and moisture retention with Sodium Hyaluronate (SH) and Glycerin
- Defends – Helps fight against daily environmental stressors with an intensive anti-oxidant blend of polyphenol-rich Green Tea Extract, stabilized Vitamin C and E, and Melanin
How to Use
Apply 15 minutes before sun exposure
Active Ingredients
Human Growth Factors – support the skin’s natural functions to promote skin rejuvenation and repair.
Octinoxate 7.5% and Zinc Oxide 7.3% – UVA and UVB filters that provide broad-spectrum protection against sun damage.
Sodium Hyaluronate – derived from hyaluronic acid, it penetrates deeper into the skin to provide intense hydration and helps the skin retain moisture by preventing transepidermal water loss.
Glycerin – a hydrating agent that acts as a humectant, giving the skin long-lasting hydration.
Vitamins C and E and Melanin – synergistic anti-oxidant care.
Product Overview
Product Type:
- Sun Care
Skin Concern:
- Anti-Aging
- Dry Skin
- Oily Skin
- Sensitive Skin
- Sun Exposure
Skin Type:
- Combination
- Normal
- Normal to Oily
- Oily
Formulation:
- Lotion
Application Area: Face
Active Ingredients:
- Antioxidants
- Vitamin C
- Collagen
- Green Tea
- Hyaluronic Acid
- Zinc Oxide






Reviews
There are no reviews yet.